000			02208 a2200649 4500
005			20250515194432.0
264		0	_c20100209
008			201002s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/sj.bjc.6605448 _2doi
040			_aNLM _beng _cNLM
100	1		_aEl-Sahwi, K
245	0	0	_aIn vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. _h[electronic resource]
260			_bBritish journal of cancer _cJan 2010
300			_a134-43 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma, Papillary _xpathology
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibody-Dependent Cell Cytotoxicity _xdrug effects
650	0	4	_aCell Line, Tumor _xdrug effects
650	0	4	_aComplement System Proteins _ximmunology
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aDimerization
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _ximmunology
650	0	4	_aIn Vitro Techniques
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aLymphocytes _ximmunology
650	0	4	_aMiddle Aged
650	0	4	_aReceptor, ErbB-2 _xbiosynthesis
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTrastuzumab
650	0	4	_aUterine Neoplasms _xpathology
700	1		_aBellone, S
700	1		_aCocco, E
700	1		_aCargnelutti, M
700	1		_aCasagrande, F
700	1		_aBellone, M
700	1		_aAbu-Khalaf, M
700	1		_aBuza, N
700	1		_aTavassoli, F A
700	1		_aHui, P
700	1		_aSilasi, D-A
700	1		_aAzodi, M
700	1		_aSchwartz, P E
700	1		_aRutherford, T J
700	1		_aPecorelli, S
700	1		_aSantin, A D
773	0		_tBritish journal of cancer _gvol. 102 _gno. 1 _gp. 134-43
856	4	0	_uhttps://doi.org/10.1038/sj.bjc.6605448 _zAvailable from publisher's website
999			_c19306434 _d19306434